PHD, VP Corporate Strategy & Development, Karius
Biography
Meredith is a passionate strategist for precision medicine, and loves bringing together the right partners to make real change in patient care. Meredith integrates scientific, technical, clinical and commercial insights to drive corporate strategy, business development, and investor relations for Karius. Prior to joining Karius she was an Associate Partner at McKinsey and Company in the healthcare practice, where she specialized in developing growth strategies for precision medicine companies, led clinical and partnership strategies with national healthcare providers, and developed successful market entry approaches for both diagnostic and therapeutic products. She holds both a Ph.D. in Neurobiology and Behavior and a BS in Biochemistry and Molecular Biology.
Microbial Profiling Showcase:
Karius
Karius is a life sciences company transforming infectious disease diagnostics with genomics. The company’s genomics platform delivers unprecedented insight into the microbial landscape through the innovative use of next-generation sequencing to analyze microbial cell-free DNA, identifying over 1000 pathogens from a blood draw.
Microbial Profiling in Precision Medicine
Microbial cell free DNA as a tool to drive higher diagnostic yield in diagnosis and surveillance
Session Abstract – PMWC 2022 Silicon Valley
Track 7 - June 28 4.00 P.M.-4.15 P.M.,Track 7 - June 29 2.30 P.M.-2.45 P.M.,Track 7 - June 30 2.00 P.M.-2.15 P.M.
The PMWC 2022 Microbial Profiling Showcase will provide a 15-minute time slot for selected companies in the Microbiome and Pathogen ID fields. The human microbiome is composed of a wide variety of microorganisms that are essential for maintaining human health and preventing disease. Research in this area is accelerating due to the rapid development in genome sequencing technologies. This showcase will present some of the leading companies in microbial profiling and pathogen identification.
